Surviving an FDA Inspection of Your Clinical Trial Site
The Investigational New Drug (IND) regulations went into effect in 1963. Ever since, the U.S. Food and Drug Administration (FDA) has conducted clinical site inspections under what is known as the Bioresearch Monitoring Program. The agency now conducts several hundred inspections of clinical investigators annually to obtain compliance with the regulations and to ensure that data submitted to the FDA are substantiated by appropriate records.
jordan release dateAir Jordan Release Dates 2021 UpdatedRead more: Surviving an FDA Inspection of Your Clinical Trial Site